Background {#Sec1}
==========

Hypopharyngeal cancer accounts for approximately 5% of all head and neck cancers \[[@CR1], [@CR2]\]. Anatomically, the hypopharynx extends from the plane of the hyoid bone above to the plane of the inferior border of the cricoid cartilage below. Hypopharyngeal cancer usually does not cause symptoms until late in the disease course \[[@CR3]\] and has a higher incidence of early metastasis and poorer prognosis than laryngeal cancer \[[@CR4]\].

Hypopharyngeal cancer is relatively uncommon and anatomically complex. Various treatment options have been used based on its stage \[[@CR5]\]. The results of radiotherapy alone are comparable to those of partial surgery for early hypopharyngeal cancer \[[@CR6]\]. Surgical resection, followed by radiotherapy, if necessary, reportedly results in a better survival rate in patients with advanced cancers \[[@CR7], [@CR8]\]. However, the potential consequences of a radical surgical approach include significant alterations in voice and swallowing function, or complete loss of one or both. Complications such as fistulas and stenosis are common, and patients may require further surgery if they survive \[[@CR5]\]. Therefore, it is important to select the best treatment option.

Pretreatment diagnosis includes histologic confirmation and staging. Although squamous cell carcinoma comprises more than 90% of cancers of the hypopharynx \[[@CR9]\], histological confirmation of the tumor is essential. Direct visualization of the lesion using a rigid laryngoscope under general anesthesia and tissue sampling is currently the standard diagnostic method. Patients with hypopharyngeal cancer are usually of old age and present with medical comorbidities. Therefore, a surgical procedure under general anesthesia is a burden for both the patient and the surgeon.

Upper gastrointestinal endoscopes have some advantages over rigid or flexible laryngoscopes, as they have better resolution and flexibility and can detect concomitant esophageal squamous dysplasia or carcinoma. Wang et al. \[[@CR10]\] described the evaluation of upper gastrointestinal non-neoplastic lesions using an ultrathin endoscope. Due to the risk of bleeding and airway obstruction, however, tissue sampling using a gastroscope is not the procedure of choice. As of yet, no standard diagnostic test has been established. The present study aimed to evaluate the feasibility of gastroscopy for the evaluation of tumor extent, and the safety of tissue sampling using a gastroscope.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

The medical records of consecutive primary hypopharyngeal cancer patients who underwent esophagogastroduodenoscopy (EGD) from March 2014 to March 2017 at International St. Mary's Hospital were retrospectively reviewed. Hypopharyngeal tumors were detected via neck computed tomography (CT), magnetic resonance imaging (MRI), and/or laryngoscopy before EGD. All study protocols were retrospectively approved by our institutional review board (submission number IS17RASI0065).

EGD and tissue sampling {#Sec4}
-----------------------

One endoscopist (Kim YJ) performed all EGD procedures in the presence of one head and neck surgeon (Hong HJ). A single-channel gastroscope (GIF-Q260J, Olympus, Tokyo, Japan) or an ultrathin endoscope (GIF-XP260N, Olympus, Tokyo, Japan) was used with or without sedation. Tissue sampling was performed using disposable biopsy forceps (FB-230 K, Olympus, Tokyo, Japan). Inspection, photography, and narrow-band imaging of hypopharyngeal lesions were performed both before and after passage through the pyriform sinus. During EGD, primary tumor extent, scope passage through the pyriform sinus, number of tissue samples taken using biopsy forceps, and the presence or absence of concomitant esophageal and gastric lesions were recorded. After EGD, we also assessed the accuracy of diagnosis based on EGD-guided biopsy histology and post-procedure complications, including post-biopsy hemorrhage or perforation. The accuracy of pathologic diagnosis using EGD guided forceps biopsy and passage of the endoscope through the tumor were evaluated.

Results {#Sec5}
=======

Table [1](#Tab1){ref-type="table"} shows the demographic data and clinical staging of the nine patients. All patients were male, with a mean age of 69.9 ± 10.9 years (range 61--69 years). Five patients underwent concurrent chemoradiation therapy, and the other four were administered best palliative care.Table 1Demographic data and clinical stages of the enrolled patientsPatient numberSexAge range (years)StageTreatment00298963male65--70cT2N0M0,CCRT00298607male60--65cT4aN0MxcT4aN0Mx00272563male60--65cT4aN2cMxCCRT00164374male75--80cT4aN1MxCCRT00294335male85--90cT4bN2cMxbest supportive care00252398male50--55cT2N2bMxCCRT00247856male80--85cT4bN2bMxbest supportive care00225664male60--65--best supportive care00176506male75--80cT4aN2cMxbest supportive care*CCRT* concurrent chemoradiation therapy

Tumors were located in the pyriform sinus, post-cricoid area, and posterior pharyngeal wall (Fig. [1](#Fig1){ref-type="fig"}). The lesions were located in the pyriform sinus in 5/9 patients (Table [2](#Tab2){ref-type="table"}). Endoscopy was observed in real time by one ear, nose, and throat specialist (Hong HJ) (Additional file 1: Video S1), who assessed tumor location and extent, as well as the involvement of the pyriform sinus inlet.Fig. 1Hypopharyngeal cancers at different locations. **a** Pyriform sinus, **b** posterior pharyngeal wall, **c** post-cricoid areaTable 2Results of esophagogastroduodenoscopy in the enrolled patientsPatient numberSexAge range\
(years)SedationLocationHistologic diagnosis using EGD forcepsComplicationPassage of scopeNumber of biopsied tissue fragmentsConcomitant upper gastrointestinal disease00298963male65--70+posterior pharyngeal wall and pyriform sinus--noyes0reflux esophagitis, gastric polyp, duodenal ulcer active stage00298607male60--65--pyriform sinussquamous cell carcinomanoyes4atrophic gastritis, intestinal metaplasia00272563male60--65--pyriform sinussquamous cell carcinomanoyes3duodenal polyp00164374male75--80+pyriform sinussquamous cell carcinomanoyes3atrophic gastritis, intestinal metaplasia00294335male85--90+pyriform sinusa few necrotic atypical squamous cellsnono^a^3atrophic gastritis, intestinal metaplasia00252398male50--55+postcricoid areasquamous cell carcinomanoyes2Gastric ulcer scar00247856male80--85+posteriorpharyngeal wallsquamous cell carcinomanoyes300225664male60--65--posterior pharyngeal wall--noyes0esophageal candidiasis00176506male75--80--posterior pharyngeal wall/postcricoid area--nono0*EGD* esophagogastroduodenoscopy, ^a^Ultrathin scope passed through the pyriform sinus

**Additional file 1:** EGD-guided forceps biopsy for hypopharyngeal cancer. The gastroscope passed through the opposite side of the tumor to avoid bleeding. After observing the esopahgus, stomach and duodenum, the distal border of the tumor was assessed while withdrawing the scope. Tissue sampling was performed using biopsy forceps. (MP4 37513 kb)

EGD was performed with sedation in six patients and without sedation in three. The sedatives used were midazolam (0.07--0.15 mg/kg, intravenous) and pethidine (25--50 mg, intravenous). In two patients, the endoscope could not pass through the hypopharyngeal mass. In one patient, only an ultrathin endoscope could pass through the mass. Biopsy using forceps was performed in 6/9 patients (66.7%) (Fig. [2](#Fig2){ref-type="fig"}). In 3/9 patients, the role of EGD was confined to the evaluation of tumor extent. The success rate of forceps biopsy was 83.3% (5/6 patients). The number of tissue fragments ranged from two to four. The success of forceps biopsy was not significantly associated with the number of tissue fragments, location of the lesion, or use of sedation.Fig. 2Tissue sample collection using biopsy forceps

Procedures were performed on hospitalized patients. No complications related to moderate sedation or biopsy, including respiratory distress or post-biopsy bleeding, were reported. Concomitant upper gastrointestinal lesions included esophageal candidiasis, intestinal metaplasia, peptic ulcer scar, and duodenal polyp. No synchronous cancers were detected.

Discussion {#Sec6}
==========

In the United States and Canada, 65--85% of hypopharyngeal carcinomas involve the pyriform sinuses, 10--20% involve the posterior pharyngeal wall, and 5--15% involve the post-cricoid area \[[@CR11]\]. Due to its anatomical complexity, no standard treatment for cancer of the hypopharynx has been established. Expert guidelines recommend surgical resection for T1 cancer \[[@CR12]\]. Expert guidelines recommend biopsy of the primary site or fine-needle aspiration of the neck, chest CT, CT with contrast, and/or MRI with contrast of the primary site and neck, and endoscopy under anesthesia for pretreatment evaluation \[[@CR12]\]. To select surgical candidates, tumor extent should be evaluated. Rigid laryngoscopy under general anesthesia is usually the diagnostic method of choice.

Developments in endoscopy have made minimally invasive treatment possible in diseases of various organs. Flexible endoscopy has advantages over rigid laryngoscopy in that it is less uncomfortable for patients and does not require sedation. Gastrointestinal endoscopy yields better resolution than flexible laryngoscopy, and enables the concomitant evaluation of esophageal, gastric, and duodenal lesions.

Five studies have reported that office-based biopsy for head and neck cancers under local anesthesia using flexible digital video laryngoscopy or transnasal fiberoptic endoscopy is safe and can successfully yield a histopathological diagnosis \[[@CR13]--[@CR17]\]. Of these five studies, three included hypopharyngeal cancer patients (*n* = 2 a, *n* = 8 d *n* = 8), while the other two included only laryngeal cancer patients. Hypopharyngeal cancer extends below the pyriform sinus inlet, and sometimes lesions are not visible via laryngoscopy. Moreover, the incidence of synchronous esophageal dysplasia or carcinoma is higher in patients with hypopharyngeal cancer than in the general population, and upper gastrointestinal endoscopy is essential. Biopsy and upper gastrointestinal evaluation can be achieved using upper gastrointestinal endoscopes.

The success rate of tissue biopsy was 83.3% in the current study. In a previous study of hypopharyngeal cancer, the success rate was 100% \[[@CR13]\]. The reported success rates of forceps biopsy through an endoscope biopsy channel in this and previous studies are acceptable; however, the currently available reported sample sizes are small.

No complications, including post-biopsy bleeding or respiratory distress during endoscopy, were observed in the present study. Mild to moderate sedation is needed, however, due to retching.

The study had some limitations. First, it was a single-center retrospective study, which may limit the reach of the conclusions; second, the study had a small sample size.

Conclusions {#Sec7}
===========

EGD appears to be a feasible option for the pretreatment diagnosis and biopsy of hypopharyngeal cancer; our limited sample size showed that an acceptable success rate may be achieved. EGD can reduce the burden of general anesthesia and enables the concomitant evaluation of upper gastrointestinal lesions.
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